169 related articles for article (PubMed ID: 1362267)
1. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.
Costall B; Naylor RJ
Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267
[TBL] [Abstract][Full Text] [Related]
2. The psychopharmacology of 5-HT3 receptors.
Costall B; Naylor RJ; Tyers MB
Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
[TBL] [Abstract][Full Text] [Related]
3. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
Costall B; Naylor RJ
Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties and functions of central 5-HT3 receptors.
Costall B; Naylor RJ
Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic potential of 5-HT3 receptor antagonists.
Costall B; Naylor RJ
Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron.
Toral J; Hu W; Critchett D; Solomon AJ; Barrett JE; Sokol PT; Ziai MR
J Pharm Pharmacol; 1995 Jul; 47(7):618-22. PubMed ID: 8568632
[TBL] [Abstract][Full Text] [Related]
7. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.
Greenshaw AJ
Trends Pharmacol Sci; 1993 Jul; 14(7):265-70. PubMed ID: 8105596
[TBL] [Abstract][Full Text] [Related]
8. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
9. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
[TBL] [Abstract][Full Text] [Related]
10. The breadth of action of the 5-HT3 receptor antagonists.
Costall B
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():3-9. PubMed ID: 8201244
[TBL] [Abstract][Full Text] [Related]
11. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
Rodgers RJ; Cole JC; Tredwell JM
Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
[TBL] [Abstract][Full Text] [Related]
13. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
14. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists.
Wolf H
Scand J Rheumatol Suppl; 2000; 113():37-45. PubMed ID: 11028830
[TBL] [Abstract][Full Text] [Related]
16. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
Płaźnik A; Kostowski W; Stefański R
Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
[TBL] [Abstract][Full Text] [Related]
17. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases].
Broocks A
Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.
Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
Neuropharmacology; 1993 Oct; 32(10):987-93. PubMed ID: 7905195
[TBL] [Abstract][Full Text] [Related]
19. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
20. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
